Risk stratification and medical therapy of pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. The recent progress observed in medical therapy of PAH is not, therefore, related to the discovery of new pathways, but to the development of new strategies for combination therapy and on escalation of treatments based on systematic assessment of clinical response. The current treatment strategy is based on the severity of the newly diagnosed PAH patient as assessed by a multiparametric risk stratification approach. Clinical, exercise, right ventricular function and haemodynamic parameters are combined to define a low-, intermediate- or high-risk status according to the expected 1-year mortality. The current treatment algorithm provides the most appropriate initial strategy, including monotherapy, or double or triple combination therapy. Further treatment escalation is required in case low-risk status is not achieved in planned follow-up assessments. Lung transplantation may be required in most advanced cases on maximal medical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 Time-course of completed randomised controlled trials (RCTs) in pulmonary arterial hypertension (PAH) (n=41) according to treatment strategy. SSc: systemic sclerosis; IPAH: idiopathic PAH. Reproduced and modified from [70] with permission.](https://figures.cochat.ai/paper-figures/44281cb9913845f29b53a42c8e3258e5/risk-stratification-and-medical-therapy-of-pulmonary-arterial-hypertension-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other high-risk profiles include familial PAH, PVOD, CTD-PAH, CTD-PAH associated with concomitant ILD, rapidly progressive disease despite therapy, and development of hemoptysis.(282, 291–293)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In particular, the 2018 World Symposium on Pulmonary Hypertension strongly recommends serial parametric risk assessment.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“The 2018 World Symposium on Pulmonary Hypertension states that the ultimate goal of therapy for patients with PAH is to achieve a low-risk status, assessed either by REVEAL or the ESC/ERS model.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationInhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationBenza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Self-citationChannick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Self-citation
Research works printed but not linked: 2
- Benza, 2018, Comparison of three assessment strategies as predictors of one-year survival in US pulmonary arterial hypertension (PAH) patients, Am J Respir Crit Care Med, 197, A7649
- Galiè, 2014, AMBITION: a randomised, multicenter study of first-line ambrisentan and tadalafil combination therapy in subjects with pulmonary arterial hypertension (PAH), Eur Respir J, 44, 2916
Cited by
Items 701–800 of 897
Cardiac Catheterization in Pulmonary Hypertension
Kovács, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11576-4
Getting to the bottom of right heart failure
Köestenberger, M., Bogaard, H. J., & Hansmann, G. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-565
Potential of Selexipag in Chronic Thromboembolic Pulmonary Hypertension Medical Therapy
Kondo, T., Nakano, Y., & Adachi, S. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0879
Badagliacca, R., D’Alto, M., Ghio, S., Vizza, C. D., & Naeije, R. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3834le
Controversies and advances in connective tissue disease‐related pulmonary arterial hypertension
Morrisroe, K., & Nikpour, M. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13926
Luknar, M., Lesný, P., Svetlošák, M., Hlivák, P., & Gonçalvesová, E. (2020) · Cardiology letters · doi:10.4149/cardiol_2020_4_11
Филиппов, Е. В. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-11-11
Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated
Bogaard, H. J., & Sitbon, O. (2021) · European Respiratory Journal · doi:10.1183/13993003.04258-2020
ERS International Congress 2020: highlights from the Thoracic Surgery and Transplantation Assembly
Esendagli, D. R., Shah, U. B., Batıhan, G., Magouliotis, D. E., Meloni, F., Vos, R., Elia, S., & Hellemons, M. E. (2021) · ERJ Open Research · doi:10.1183/23120541.00743-2020
Conger, A. K., Halliday, S. J., Pugh, M. E., Robbins, I. M., & Hemnes, A. R. (2021) · Research Square · doi:10.21203/rs.3.rs-70022/v2
Sakamaki, F., & Asano, K. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0030
A 44-Year-Old Man Presenting With Massive Hemoptysis and Dyspnea
Oppegard, L. J., Hedstrom, G., Levene, J., Desai, S. S., Khan, A., & Tsui, J. L. (2021) · CHEST Journal · doi:10.1016/j.chest.2020.11.058
Pulmonary hypertension: clinical phenotypes and non-invasive risk stratification
Lewis, R. A. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
10. (virtuálne) stretnutie zástupcov centier pre pľúcnu artériovú hypertenziu
Luknar, M. (2021) · Cardiology letters · doi:10.4149/cardiol_2021_1_11
Identifying New Targets for Treatment of Pulmonary Hypertension
Trammell, A. W., & Hart, C. M. (2021) · CHEST Journal · doi:10.1016/j.chest.2020.10.065
Su, L., Cai, G., Zhang, L., Cui, Z., Yang, L., Sun, J., Cai, L., Yang, L., Xu, X., Wang, L., et al. (2021) · Archives of Medical Science · doi:10.5114/aoms/136345
Church, C., Gin‐Sing, W., Grady, D., Johnson, M., Kiely, D. G., Lordan, J. L., Turner, N., Wort, S. J., & Condliffe, R. A. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1931129
PULMONARY ARTERIAL HYPERTENSION: REGIONAL HEALTH CARE OPPORTUNITIES
Филиппов, Е. В. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-2-84-91
Pulmonale Hypertonie und Rechtsherzinsuffizienz
Rosenkranz, S. (2021) · Aktuelle Kardiologie · doi:10.1055/a-1511-2519
Karlócai, K., Ablonczy, L., Ágoston, G., Bálint, O. H., Csósza, G., Daragó, A., Faludi, R., Forster, T., Péter, A., Temesvari, A., et al. (2020) · SZTE Publicatio Repozitórium (University of Szeged)
Treating the Right Ventricle Directly in Pulmonary Hypertension
Voelkel, N. F., Schranz, D., Botros, L., & Bogaard, H. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-78255-9_21
Acute Right-Heart Failure in Patients with Chronic Precapillary Pulmonary Hypertension
Savale, L., Boucly, A., Pichon, J., Roche, A., & Humbert, M. J. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-78255-9_17
Genin, V., Horeau-Langlard, D., Diot, É., Gagnadoux, F., Lavigne, C., Fournet, M., Durant, C., & Agard, C. (2021) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.07.009
Cardiopulmonary Monitoring of Patients with Pulmonary Hypertension and Right Ventricular Failure
Davey, R., Alohali, A. F., Jia, S., & Mehta, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-73387-2_54
Rezukhina, E. A., Rodnenkov, O. V., & Martynyuk, T. V. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-3010
A bad old day on acting's Everest
Montgomery, J. (1997) · TLS, the Times literary supplement/Times literary supplement on CD-ROM/TLS. Times literary supplement
Reply to Jin et al. and to Sun et al.
Boucly, A., Weatherald, J. C., Savale, L., Jaïs, X., Montani, D., Humbert, M. J. C., & Sitbon, O. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202107-1725le
Use of Wearables and Implantable Devices to Monitor Pulmonary Health in the Outpatient Setting
Glinskii, V. V., Lyn, R., Thomas, C., & Pérez, V. D. J. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202102-0462rr
Gas exchange: the neglected piece in the PAH puzzle
Hassoun, P. M., Souza, R., & Hoeper, M. M. (2021) · European Respiratory Journal · doi:10.1183/13993003.01407-2021
Pulmonale Hypertonie: Differenzialdiagnostik und therapeutische Konsequenzen
Rosenkranz, S. (2021) · Kardiologie up2date · doi:10.1055/a-1165-7581
Chronic thromboembolic pulmonary hypertension: Clinical outcomes
van Thor, M. C. J. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/903
Kovács, G. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.07.014
CURATIVE BENEFIT OF SUBMUCOPERICHONDRIAL RESECTION OPERATION ON PULMONARY AR
Sheikh, N. A., Choudhary, A. A., Nadeem, K., Khursheed, A., Fatima, R., & Shah, S. A. A. (2021) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v1i1.7933
Utility of plasma volume status in ambulatory patients with pulmonary hypertension
Sternberg, M. E., Grinnan, D., & Gertz, Z. M. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12045
Macitentan and Tadalafil (Opsynvi)
Reimbursement Team (2022) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2022.268
Khatab, Y., Ghafouri, S. R., Alkhateeb, H., Mukherjee, D., García, H., & Nickel, N. P. (2022) · Cardiology Research · doi:10.14740/cr1362
(2022) · Advances in Pulmonary Hypertension · doi:10.21693/1933-0898-21.1.i
Faculty Opinions recommendation of An overview of the 6th World Symposium on Pulmonary Hypertension.
Pérez, V. D. J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735150591.793561112
Weatherald, J. C., Mehta, S., & Hirsch, A. M. (2021) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2021.1888040
Pizarro, C., & Skowasch, D. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23834-5.00022-0
Palazzini, M., Galiè, N., & Manes, A. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198849346.003.0063
Self-citationPrognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertensionPreprint
Xanthouli, P., Theobald, V., Benjamin, N., Marra, A. M., D'Agostino, A. G., Egenlauf, B., Shaukat, M., Ding, C., Cittadini, A., Bossone, E., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-853248/v1
Self-citationBiomarkers in Pulmonary Hypertension
Inampudi, C., & Hemnes, A. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11656-3
Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
Li, X., Kosanovic, D., Wang, X., & Cao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910212
Cao, R., & Guo, Z. (2022) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14398
(2022) · European Respiratory Society eBooks · doi:10.1183/9781849841610.0128.2022
Multiple Choice Questions with explanations
(2022) · European Respiratory Society eBooks · doi:10.1183/9781849841610.chapter1
McLaughlin, V. V., Channick, R. N., Lynum, K. S. B., Oudiz, R. J., Selej, M., Tapson, V. F., & Rubin, L. J. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12134
Self-citationHan, X., Zhang, Y., Zhang, X., Ji, H., Wang, W.-Z., Qiao, O., Li, X., Wang, J., Li, D.-K., Ju, A., et al. (2022) · Phytomedicine Plus · doi:10.1016/j.phyplu.2022.100338
Arena, R. A., Ozemek, C., Canada, J. M., Lavie, C. J., Borghi‐Silva, A., Bond, S., Popović, D., Argiento, P., & Guazzi, M. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101423
Mlakar, P., Lestan, D., & Salobir, B. (2022) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3330
7. State of the Art Pulmonary Hypertension Treatment
Matsubara, H. (2021) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.110.1951
Demerouti, E., & Tsiapras, D. P. (2022) · Journal of Clinical Cardiology · doi:10.33696/cardiology.3.031
Esclerodermia sistémica: tratamiento
Allanore, Y. (2022) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(22)47186-3
Nomograms and RALP Techniques for Management of ECE: Partial Nerve Sparing
Rocco, B. M. C., Sarchi, L., Calcagnile, T., Cooperberg, M. R., Gang, Z., Vis, A. N., Assumma, S., Bozzini, G., & Sighinolfi, M. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-00363-9_21
(2022) · Advances in Pulmonary Hypertension · doi:10.21693/1933-0898-21.4.i
Human Immunodeficiency Virus–Associated Pulmonary Arterial Hypertension
Kolaitis, N. A., & Barnett, C. F. (2022) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-21.4.115
Interstitial lung diseases and secondary pulmonary hypertension
Belić, S., Marić, N., Đurđević, N., Golubovic, A., Milivojević, I., Geratović, M., Nikolić, N., Čokrlić, I., & Stjepanović, M. (2023) · Srpski medicinski casopis Lekarske komore · doi:10.5937/smclk4-41136
Progress in the Management of Pulmonary Hypertension
Ogo, T. (2022) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.111.836
Pulmonary arterial hypertension: available treatments in the modern era
Manzi, G., Scoccia, G., Adamo, F. I., Caputo, A., Jabbour, J. P., Manguso, G., Recchioni, T., Rubino, G., Serino, G., Xu, W. M., et al. (2022) · Medical Academy Journal · doi:10.56823/yory4349
Features of a telomere syndrome in patients with idiopathic pulmonary fibrosis
Hoffman, T. W. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1359
Camacho, R. E. C., Orozco‐Levi, M., Londoño, A., Acosta, D. F., Alvarado, J. J., Carvajal, J. F., Camargo-Mendoza, J. P., Gómez-Paláu, R., Martínez-Ramírez, I. J., Méndez, J., et al. (2023) · Revista Colombiana de Cardiología (English Edition) · doi:10.24875/rccare.m22000015
Computational Hemodynamic Modeling of Pediatric Cardiovascular Diseases
Tossas-Betancourt, C. (2023) · Deep Blue (University of Michigan) · doi:10.7302/7372
Propuesta de consenso y posición sobre hipertensión pulmonar 2022. Sociedad Peruana de Cardiología
Aguirre-Zurita, O., Cárdenas-Lévano, L. R., Correa-Flores, R. M., Diaz-Lazo, A. V., Sánchez, J. G. E., Salcedo, J. O. M., Pariona-Javier, M. L., Paucca-Montoya, E. R., Urteaga, Z. R., Pérez, E. S. S., et al. (2023) · Revista Peruana de Cardiología · doi:10.24875/rperc.m23000005
Даценко, І. С., & Кабачна, А. В. (2022) · Farmatsevtychnyi zhurnal · doi:10.32352/0367-3057.4.22.04
Ma, R., Zhang, X., Cheng, L., Li, X., Mu, C., Gui, W., Deng, Y. L., Zhao, M., & Ren, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3343789/v1
Menéndez, S. C. (2023) · Gredos (University of Salamanca) · doi:10.14201/gredos.153121
Wang, B., Cheng, J., Li, Z., & Peng, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.27.564313
Revealing the Resilient Right: Insights into Mechanisms of Right Heart Adaptation
van Wezenbeek, J. C. C. M. (2023) · doi:10.5463/thesis.448
Lung Transplantation for Pulmonary Artery Hypertension
Sunder, T., Thangaraj, P. R., Kuppusamy, M. K., Sriraman, K. B., Selvi, C., & Kumar, S. Y. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002961
ԹՈՔԱՅԻՆ ԶԱՐԿԵՐԱԿԱՅԻՆ ՀԻՊԵՐՏԵՆԶԻԱ
Minasyan, A., Khachatryan, T. A., Melkonyan, E. G., Meloyan, S. V., & Tavaratsyan, A. R. (2023) · MEDICINE SCIENCE AND EDUCATION · doi:10.56936/18291775-2023.36-16
Yaqoob, M., DeCato, T. W., & Oudiz, R. J. (2024) · Current Respiratory Medicine Reviews · doi:10.2174/011573398x268093231226043639
Idiopathic Pulmonary Hypertension and in Situ Thromboembolism: A Difficult Case in Clinical Practice
Us, M. A., & Karpenko, J. J. (2024) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2023-13-6-466-477
Ye, H., Sun, X., Sun, X., Wu, Q., Zhou, Z., Li, D., Zhou, Y., Zhang, M., Wang, Q., & Gu, L. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.122939
Marqueurs pronostiques et stratification du risque dans l’HTAP
Boucly, A. (2021) · theses.fr (ABES) · doi:10.70675/5ed4fe2cz1e57z41c5zac6az4af0eec45aa6
León, J. S. T., Pedraza, M. P. M., Pedraza, J. A. N., Medina, N. J. M., Patiño, M. A. D., López, J. A. E., Vega, S. Y. V., Rivero, J., & Campo, E. R. Z. (2024) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v8i2.10294
Eid, M., Kasem, A., Kamal, Y. M., Hamdy, M., & Gaber, M. (2024) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_92_23
Microbiota and pulmonary hypertension: a systematic review on human studiesPreprint
Yarmohammadi, H., Soltanipur, M., Rezaei, M., Soroush, E., Mahalleh, M., Razavi, A., Raei, M., Yaghmaei, H., Mirhosseini, S. M., & Siadat, S. D. (2024) · Research Square · doi:10.21203/rs.3.rs-4036543/v1
Overview of Management and Outcome Assessment in Systemic Sclerosis
Denton, C. P., Shah, A. A., & Allanore, Y. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_41
Management of the Scleroderma Patient with Pulmonary Arterial Hypertension Failing Initial Therapy
Mullin, C. J., & Mathai, S. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_53
Portopulmonary hypertension: peculiarities of diagnosis and treatment
Chooklin, S., Chuklin, S. S., Posivnych, M. M., & Krystopchuk, S. A. (2024) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.20.3.2024.1686
Exploration of mitochondrial-related biomarkers and regulatory mechanisms in pulmonary hypertensionPreprint
Hao, Y., Wu, P., Zhao, W., Cheng, H., Zhang, H., Wu, H., Chen, D., Ma, X., & Yan, N. (2024) · Research Square · doi:10.21203/rs.3.rs-4301187/v1
OS PRINCIPAIS DESAFIOS E AS PERSPECTIVAS NO DIAGNÓSTICO E TRATAMENTO DA HIPERTENSÃO PULMONAR
Trindade, A. C., do Monte, B. B., de Andrade, B. V., Furquim, E. C. G., Filho, H. J. D. C. F., Ribeiro, I. G., de Miranda, M. G., Lima, M. D. A., & Uziel, S. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024479p349
Cersosimo, A., Barca, L., Condello, F., & Vizzardi, E. (2024) · Echocardiography · doi:10.1111/echo.15869
Chen, J., Xu, N., Xu, X., & Chen, L. (2024) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.917
Advancements in Pulmonary Hypertension: Defining New Horizons!
Priya, S. N. S., & -, P. V. R. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24701133656
Farber, H. W., & Schoenberg, N. C. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.042
Ülvan, N., Koçak, A., & Özer, N. (2024) · Bulletin of Cardiovasculer Academy · doi:10.4274/kvbulten.galenos.2024.54264
Burton, K., Gold, A. K., Abt, P. L., Machado, N., Rock, K. C., & Bezinover, D. S. (2024) · Transplantation Direct · doi:10.1097/txd.0000000000001710
Berezina, A. V., Zlobina, I. S., Goncharova, N. S., Simakova, M. A., Борисович, Л. К., & Моисеева, О. М. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-4088
Nikta, B., Shariati, Z., Mosalanejad, S., Afkar, M., & Biazar, N. (2024) · Qur̓ān/pizhūhī-i khāvar/shināsān · doi:10.61186/iau.34.4.411
Guía de Práctica Clínica Mexicana de Hipertensión Pulmonar
Zayas, N., Hernández, G. E., Sandoval‐Gutiérrez, J. L., Hernandez-Oropeza, J. L., Cueto‐Robledo, G., Moreno-Hoyos, J. F., López-Estupiñán, S., García‐Aguilar, H., Marín, F. J., Palomar-Lever, A., et al. (2024) · NCT Neumología y Cirugía de Tórax · doi:10.35366/119398
Self-citationGattani, R., Goodrich-Harris, A. M., & Kennedy, J. L. W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11642-1.00009-5
Goossen, C., & Pagano, P. J. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf081
Oh, S. B., Jeon, Y. K., Choi, N., Yoo, H. Y., & Kim, S. J. (2025) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.25.122
The role of imaging in risk assessment for pulmonary arterial hypertension
Verma, D., Estrada, R. A., & Sahay, S. (2025) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001238
Pulmonary complications in liver cirrhosis
Thévenot, T., Raevens, S., Aujayeb, A., Cadranel, J., Banini, B. A., & DuBrock, H. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21938-2.00014-x
Diagnosis and Management of Pulmonary Hypertension in Pregnancy
McNamara, L. C., Mounsey, L. A., & Kholdani, C. A. (2025) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-025-00428-y
Metadata
- Authors
- Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., & McLaughlin, V. V.
- Affiliations
- University of Bologna (IT)
- Harvard University (US)
- Mayo Clinic (US)
- University Hospital Heidelberg (DE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Tufts University (US)
- Houston Methodist (US)
- International University of Health and Welfare (JP)
- University of Michigan (US)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801889
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351343
- OpenAlex
- W2904385559
- Cited by
- 819
- References
- 88
- Citations by year
- 2026: 32 · 2025: 46 · 2024: 101 · 2023: 108 · 2022: 174 · 2021: 169 · 2020: 128 · 2019: 58
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (18K08183)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- pulmonary arterial hypertension, risk stratification, medical therapy, combination therapy, treatment escalation, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostacyclin analogues, right ventricular function, exercise capacity, one-year mortality, lung transplantation, treatment algorithm
- MeSH terms
- Pulmonary Arterial Hypertension, Calcium Channel Blockers, Humans, Randomized Controlled Trials as Topic, Lung Transplantation, Practice Guidelines as Topic, Risk Assessment, Phosphodiesterase 5 Inhibitors, Endothelin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.